Inteliview
Log inSign up
월가 포트폴리오/Joseph Edelman
Joseph Edelman
Healthcare2025-12-31 기준

Joseph Edelman

Perceptive Advisors LLC

퍼셉티브 어드바이저스의 설립자. 헬스케어·바이오텍 전문 투자자로, 제약 파이프라인과 FDA 승인 분석에 탁월한 전문성을 보유하고 있다.

$5.60BAUM
104Holdings
2025-12-31 요약

6개 종목 신규 매수 (IVVD, DHR, CDTX 등) · 6개 종목 추가 매수 (ANRO, BLTE, DYN 등) · 20개 비중 축소 · PUT 1개 (XBI) · 최대 보유: PRAX 10.5%

Portfolio Heatmap

크기 = 포트폴리오 비중 · 초록 = 보유량 늘림 · 빨강 = 보유량 줄임

This Quarter's Trades

2025-12-31 기준
New Buy6건
IVVDIVVDINVIVYD INC$53.81M1.0%DHRDHRDANAHER CORPORATION$45.78M0.8%CDTXCDTXCIDARA THERAPEUTICS INC$36.48M0.7%IRONIRONDISC MEDICINE INC$35.79M0.6%PALIPALIPALISADE BIO INC$28.32M0.5%AXGNAXGNAXOGEN INC$25.66M0.5%
Added6건
ANROANROALTO NEUROSCIENCE INC$31.76M0.6%BLTEBLTEBELITE BIO INC$66.26M1.2%DYNDYNDYNE THERAPEUTICS INC$68.05M1.2%RAPTRAPTRAPT THERAPEUTICS INC$27.97M0.5%LONALONAATHIRA PHARMA INC$14.08M0.3%BSXBSXBOSTON SCIENTIFIC CORP$93.35M1.7%
Sold / Exited6건
AQSTAQSTAQUESTIVE THERAPEUTICS INC$4.83M<0.1%KYMRKYMRKYMERA THERAPEUTICS INC$5.44M<0.1%CRVSCRVSCORVUS PHARMACEUTICALS INC$5.33M<0.1%KRYSKRYSKRYSTAL BIOTECH INC$4.31M<0.1%PENPENPENUMBRA INC$34.36M0.6%ACLXACLXARCELLX INC$95.59M1.7%

Holdings

104개 종목
#
Stock ⇅
Weight ↓
SharesValue
Change ⇅
Trend
1
51.80%
50,000$800,000-New Position
2
47.85%
108,694$739,119+0.00%No Change
3
0.04%
1,995,986$588.30M+27.58%Added
4
0.02%
3,160,200$315.20M+6.90%Added
5
0.02%
2,546,391$272.57M+4.40%Added
6
0.01%
1,081,421$230.60M-0.65%Partial Sell
7
0.01%
2,330,651$175.92M+72.39%Added
8
0.01%
7,985,461$173.28M+8.37%Added
9
0.01%
1,665,105$167.49M+6.58%Added
10
0.01%
4,278,180$163.47M+12.74%Added

Options Positions

3개 포지션
CALL
20.2% 비중
PUT
12.4% 비중
P/C Ratio
0.50
TickerTypeWeightValueChgActivity
XBI
XBI
SPDR SERIES TRUST
PUT2.40%$134.12M0.0%New
CAPR
CAPR
CAPRICOR THERAPEUTICS INC
CALL0.12%$6.99M0.0%New
TECX
TECX
TECTONIC THERAPEUTIC INC
CALL0.09%$5.21M0.0%New

* 풋(PUT) 옵션은 주가 하락에 베팅하는 포지션, 콜(CALL) 옵션은 주가 상승에 베팅하는 포지션입니다.
* 풋/콜 비율이 1보다 크면 방어적, 작으면 공격적 성향으로 해석됩니다.

FAQ

Need Deeper Analysis?

Track Joseph Edelman's portfolio changes in real-time,
compare gurus head-to-head, and analyze performance vs S&P 500 with Premium.

Start Premium